ANIONICALLY MODIFIED N-SULFONIC POLYALLYLAMINE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE N-SULFONIC POLYALLYLAMINE DERIVATIVE AS THE ACTIVE SUBSTANCE AND USE OF THE N-SULFONIC POLYALLYLAMINE DERIVATIVE FOR THE PRODUCTION OF A MEDICINE
The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO3− or —H, and n is an integer from 150 to 15000 an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.
